Global Bio Medical Textile Market Overview:
According to SPER Market Research, the Global Bio Medical Textile Market is estimated to reach USD 26.29 billion by 2032 with a CAGR of 5.98%.
Biomedical textiles are fibrous structures designed for use in specific biological environments. The fibers used in these textiles should possess antimicrobial, fire-resistant, non-allergic, and non-carcinogenic properties. They are produced using weaving, non-weaving, and knitting technologies for surgical sutures, implantable, extracorporeal devices, and non-implantable applications non-implantable applications include bandages, gauze, glue, sticky and tubular and triangular. Surgical sutures can be made from both biodegradable and non-biodegradable fibers and are used to close surgical wounds. Implantable biomedical textiles are made of biodegradable fibers that can be used in specific biological environments and are biocompatible and biostable to cells and body fluids. Biomedical textiles are also used in extracorporeal devices as mechanical organs used for blood purification.
Impact of COVID-19 on the Global Bio Medical Textile Market:
Covid-19 is an incomparable global public fitness emergency that has affected almost every industry, and the lengthy-term results are projected to impact the industry increase all through the forecast period. Our ongoing studies amplifies our studies framework to make certain the inclusion of underlying covid-19 problems and potential paths forward. The record promises insights on covid-19 thinking about the adjustments in consumer behavior and demand, shopping patterns, re-routing of the supply chain, dynamics of cutting-edge marketplace forces, and the vast interventions of governments. The up to date have a look at gives insights, analysis, estimations, and forecasts, thinking about the COVID-19 impact available on the market.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2032 |
| Base year considered | 2021 |
| Forecast period | 2022-2032 |
| Segments covered | By Fiber Type, By Fabric Type, By Application, By End User |
| Regions covered | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Companies Covered | Atex Technologies, B. Braun Melsungen AG, Cardinal Health, Confluent Medical Technologies, Fiber Portfolio, Integra LifeSciences Corporation, Johnson & Johnson Services Inc., Medline Industries Inc., Meister & Cie AG, Paul Hartmann AG, Royal DSM.
|
Global Bio Medical Textile Market Segmentation:
By Fiber Type: Based on the Fiber Type, Global Bio Medical Textile Market is segmented as; Biodegradable, Non-Biodegradable.
By Fabric Type: Based on the Fabric Type, Global Bio Medical Textile Market is segmented as; Non-woven, Woven.
By Application: Based on the Application, Global Bio Medical Textile Market is segmented as; Implantable, Surgical Sutures.
By End User: Based on the End User, Global Bio Medical Textile Market is segmented as; Ambulatory Centers, Clinics, Community Healthcare, Hospitals, Others.
By Region: During the projection period, the market in APAC is expected to see the greatest CAGR because labour and raw materials are less expensive in this region than in Europe and North America, there are more chances for expansion for businesses that produce biomedical textiles. The highly populated nations like China and India, the rising income levels of the populace, and the rising costs of healthcare facilities all contribute to the region's high biomedical textile consumption.
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal Database
2.1.4. Premium Insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2. COVID-19 Impacts of the Global Bio Medical Textile Market
5. Market variables and outlook
5.1. SWOT analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL analysis
5.2.1. Political landscape
5.2.2. Economic landscape
5.2.3. Social landscape
5.2.4. Technological landscape
5.2.5. Environmental landscape
5.2.6. Legal landscape
5.3. PORTER’S five forces analysis
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of Buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat map analysis
6. Global Bio Medical Textile Market, By Fiber Type, 2019-2032 (USD million)
6.1. Biodegradable
6.2. Non-Biodegradable
7. Global Bio Medical Textile Market, By Fabric Type, 2019-2032 (USD million)
7.1. Non-woven
7.2. Woven
8. Global Bio Medical Textile Market, By Application, 2019-2032 (USD million)
8.1. Implantable
8.2. Surgical Sutures
9. Global Bio Medical Textile Market, By End User, 2019-2032 (USD million)
9.1 Ambulatory Centers
9.2 Clinics
9.3 Community Healthcare
9.4 Hospitals
9.5 Others
10. Global Bio Medical Textile Market, By Region, 2019-2032 (USD million)
10.1 North America
10.1.1 United States
10.1.2 Canada
10.1.3 Mexico
10.2 Europe
10.2.1 Germany
10.2.2 United Kingdom
10.2.3 France
10.2.4 Italy
10.2.5 Spain
10.2.6 Rest of Europe
10.3 Asia-Pacific
10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 Australia
10.3.5 South Korea
10.3.6 Rest of Asia-Pacific
10.4 South America
10.4.1 Brazil
10.4.2 Argentina
10.4.3 Rest of South America
10.5 Middle East & Africa
10.5.1 Kingdom of Saudi Arabia
10.5.2 United Arab Emirates
10.5.3 Rest of Middle East & Africa
11. Company Profiles
11.1 Atex technologies
11.1.1 Company details
11.1.2 Financial outlook
11.1.3 Product summary
11.1.4 Recent developments
11.2 B. Braun Melsungen AG
11.2.1 Company details
11.2.2 Financial outlook
11.2.3 Product summary
11.2.4 Recent developments
11.3 Cardinal Health
11.3.1 Company details
11.3.2 Financial outlook
11.3.3 Product summary
11.3.4 Recent developments
11.4 Confluent Medical Technologies
11.4.1 Company details
11.4.2 Financial outlook
11.4.3 Product summary
11.4.4 Recent developments
11.5 Fiber Portfolio
11.5.1 Company details
11.5.2 Financial outlook
11.5.3 Product summary
11.5.4 Recent developments
11.6 Integra LifeSciences Corporation
11.6.1 Company details
11.6.2 Financial outlook
11.6.3 Product summary
11.6.4 Recent developments
11.7 Johnson & Johnson Services Inc.
11.7.1 Company details
11.7.2 Financial outlook
11.7.3 Product summary
11.7.4 Recent developments
11.8 Medline Industries Inc.
11.8.1 Company details
11.8.2 Financial outlook
11.8.3 Product summary
11.8.4 Recent developments
11.9 Meister & Cie AG
11.9.1 Company details
11.9.2 Financial outlook
11.9.3 Product summary
11.9.4 Recent developments
11.10 Paul Hartmann AG
11.10.1 Company details
11.10.2 Financial outlook
11.10.3 Product summary
11.10.4 Recent developments
11.11 Royal DSM
11.11.1 Company details
11.11.2 Financial outlook
11.11.3 Product summary
11.11.4 Recent developments
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
